Laserfiche WebLink
Terms <br />Definitions <br />HHS <br />The Department of Health and Human Services or any designee of the Secretary, <br />Department of Health and Human Services. <br />Initial Drug Test <br />The test used to differentiate a negative specimen from one that requires further testing <br />for drugs or drug metabolites. <br />Invalid Drug Test <br />The result of a drug test for a urine specimen that contains an unidentified adulterant or <br />an unidentified interfering substance, has abnormal physical characteristics, or has an <br />endogenous substance at an abnormal concentration that prevents the laboratory from <br />completing or obtaining a valid drug test result. <br />Laboratory <br />Any U.S. laboratory certified by HHS under the National Laboratory Certification Program <br />as meeting the minimum standards of Subpart C of the HHS Mandatory Guidelines for <br />Federal Workplace Drug Testing Programs; or, in the case of foreign laboratories, a <br />laboratory approved for participation by DOT under this part. (The HHS Mandatory <br />Guidelines for Federal Workplace Drug Testing Programs are available on the internet at <br />http://www.health.org/workpi.htm or from the Division of Workplace Programs, 1 Choke <br />Cherry Road, Room 2-1035, Rockville, MD 20857.) <br />Medical Review <br />A person who is a licensed physician and who is responsible for receiving and reviewing <br />Officer <br />laboratory results generated by an employer's drug testing program and evaluating <br />medical explanations for certain drug test results. <br />Negative Dilute <br />A drug test result which is negative for the five drugs/drug metabolites, but has a specific <br />gravity value lower than expected for human urine. <br />Negative Result <br />A result that indicates that the specimen did not exceed certain levels of drug <br />metabolites. The average turnaround time for a negative result is 24 hours from the time <br />the laboratory receives the specimen, though this could vary. <br />Non -negative <br />A urine specimen that is reported as adulterated, substitute, invalid, or positive for <br />Specimen <br />drug/drug metabolites. <br />Positive Dilute <br />A urine drug test result which is positive for the five drugs/drug metabolites, but has a <br />specific gravity value lowerthan expected for human urine. <br />Positive Result <br />For a drug test means a verified presence of the identified drug or its metabolite at or <br />above the minimum levels specified in 49 CFR Part 40, as amended. The confirmed result <br />is sent to the MRO for review. A positive alcohol test result means a confirmed alcohol <br />concentration of 0.04 BAC or greater. <br />Primary <br />In drug testing, the urine specimen bottle 'A' that is opened and tested by a' first' <br />Specimen <br />laboratory to determine whether the employee has a drug or drug metabolite in his or her <br />system; and for the purpose of validity testing. The primary specimen is distinguished <br />from the split specimen, defined in this section. A 'second' laboratory may test bottle 'B' <br />should the donor not agree with the results from bottle W. <br />Qualification <br />The training required in order for a collector, BAT, MRO, SAP, or STT to be qualified to <br />Training <br />perform their functions in the DOT drug and alcohol testing program. Qualification <br />training may be provided by any appropriate means (e.g., classroom instruction, internet <br />application, CD—ROM, video). <br />Refresher <br />The training required periodically for qualified collectors, BATS, and STTs to review basic <br />Training <br />requirements and provide instruction concerning changes in technology (e.g., new testing <br />methods that may be authorized) and amendments, interpretations, guidance, and issues <br />concerning this part and DOT agency drug and alcohol testing regulations. Refresher <br />training can be provided by any appropriate means (e.g., classroom instruction, internet <br />application, CD—ROM, video). <br />